Niemietz, Christoph 1986-
Christoph Niemietz researcher ORCID ID = 0000-0002-9393-8748
VIAF ID: 3981158309899306690008 (Personal)
Permalink: http://viaf.org/viaf/3981158309899306690008
Preferred Forms
4xx's: Alternate Name Forms (2)
Works
| Title | Sources |
|---|---|
| Combined transgene immortalized urothelial cells capable of reprogramming and hepatic differentiation |
|
| Downregulation of hepatic multi-drug resistance protein 1 (MDR1) after copper exposure. |
|
| Evaluation of Therapeutic Oligonucleotides for Familial Amyloid Polyneuropathy in Patient-Derived Hepatocyte-Like Cells. |
|
| FAP plasma-induced cellular toxicity. |
|
| Hepatocyte-like cells reveal novel role of SerpinA1 in transthyretin amyloidosis |
|
| Methanobactin reverses acute liver failure in a rat model of Wilson disease |
|
| Mutation-specific Fabry disease patient-derived cell model to evaluate the amenability to chaperone therapy |
|
| Organic cation transporter 3 mediates cisplatin and copper cross-resistance in hepatoma cells. |
|
| Therapeutic Oligonucleotides Targeting Liver Disease: TTR Amyloidosis |
|
| Thermal shift assay for evaluation of transthyretin stability in plasma |
|
| [Transthyretin Familial Amyloid Polyneuropathy - Disease Profile of a Multisystem Disorder] |
|
| Untersuchung von induzierten pluripotenten stammzellbasierten Krankheitsmodellen bei monogenetischen Lebererkrankungen |
|
